Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity.
All-trans retinoic acid deficiency resulting from ethanol's interference with the synthesis of all-trans retinoic acid from retinol was recently suggested to cause the malformations of the fetal alcohol syndrome. Phenytoin, carbamazepine and valproate, might be teratogenic because they lower the concentration of all-trans retinoic acid in serum, by inducing the enzyme systems in the liver responsible for the metabolism of the all-trans retinoic acid, or by other mechanisms. Here we show, that in patients given therapeutic doses of phenytoin, carbamazepine and valproate, serum all-trans and 13-cis retinoic acid concentrations are indeed significantly lowered. We propose that drugs with this ability should be considered as potential teratogens.
Department of Clinical Chemistry, University Hospital of Lund, Sweden.
G
G
Fex
K
K
Larsson
A
A
Andersson
M
M
Berggren-Söderlund
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects; D013723:Teratogens; D014212:Tretinoin / Q000097:blood*; D014635:Valproic Acid / Q000009:adverse effects
D000927:Anticonvulsants; D013723:Teratogens; D002220:Carbamazepine; D014212:Tretinoin; D014635:Valproic Acid; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D015474:Isotretinoin